Milton H. Werner - Mar 1, 2023 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Milton H. Werner
Stock symbol
IKT
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 04:00 PM
Previous filing
Aug 16, 2022
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +210K $0.00 210K Mar 1, 2023 Common Stock 210K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the options will vest and become exercisable on 3/1/2024, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2024, subject to continued employment through each such vesting date.